172 related articles for article (PubMed ID: 21660476)
1. [Pathological work-up of rectal cancer following partial/total mesorectal excision].
Schmitz KJ; Chmelar C; Berg E; Schmid KW
Pathologe; 2011 Jul; 32(4):321-9. PubMed ID: 21660476
[TBL] [Abstract][Full Text] [Related]
2. The total mesorectal excision specimen for rectal cancer: a review of its pathological assessment.
Parfitt JR; Driman DK
J Clin Pathol; 2007 Aug; 60(8):849-55. PubMed ID: 17046842
[TBL] [Abstract][Full Text] [Related]
3. [Surgery for rectal cancer].
Krones CJ; Stumpf M; Schumpelick V
Chirurg; 2009 Apr; 80(4):303-10. PubMed ID: 19350307
[TBL] [Abstract][Full Text] [Related]
4. Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure?
Rahbari NN; Ulrich AB; Bruckner T; Münter M; Nickles A; Contin P; Löffler T; Reissfelder C; Koch M; Büchler MW; Weitz J
Ann Surg; 2011 Mar; 253(3):522-33. PubMed ID: 21209587
[TBL] [Abstract][Full Text] [Related]
5. [The optimult study concept - selective neoadjuvant chemoradiation therapy based on preoperative MRI].
Kreis ME; Junginger T; Rödel C; Heinemann V; Nikolaou K; Mansmann U; Jauch KW
Zentralbl Chir; 2010 Aug; 135(4):302-6. PubMed ID: 20806131
[TBL] [Abstract][Full Text] [Related]
6. Short-term preoperative radiotherapy in rectal cancer patients leads to a reduction of the detectable number of lymph nodes in resection specimens.
Maschuw K; Kress R; Ramaswamy A; Braun I; Langer P; Gerdes B
Langenbecks Arch Surg; 2006 Aug; 391(4):364-8. PubMed ID: 16683146
[TBL] [Abstract][Full Text] [Related]
7. Abdominoperineal resection for rectal cancer at a specialty center.
Nissan A; Guillem JG; Paty PB; Douglas Wong W; Minsky B; Saltz L; Cohen AM
Dis Colon Rectum; 2001 Jan; 44(1):27-35; discussion 35-6. PubMed ID: 11805560
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes by a transanal approach to total mesorectal excision for rectal cancer.
Marks JH; Myers EA; Zeger EL; Denittis AS; Gummadi M; Marks GJ
Surg Endosc; 2017 Dec; 31(12):5248-5257. PubMed ID: 28643051
[TBL] [Abstract][Full Text] [Related]
9. Lymph node status does not predict local recurrence in the total mesorectal excision era.
Chand M; Moran BJ; Jones RG; Heald RJ; Brown G
Dis Colon Rectum; 2014 Jan; 57(1):127-9. PubMed ID: 24316956
[No Abstract] [Full Text] [Related]
10. Total mesorectal excision and pelvic node dissection for rectal cancer: an appraisal.
Mortenson MM; Khatri VP; Bennett JJ; Petrelli NJ
Surg Oncol Clin N Am; 2007 Jan; 16(1):177-97. PubMed ID: 17336243
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the frequency and pattern of local recurrence following intersphincteric resection for ultra-low rectal cancer.
Abdel-Gawad W; Zaghloul A; Fakhr I; Sakr M; Shabana A; Lotayef M; Mansour O
J Egypt Natl Canc Inst; 2014 Jun; 26(2):87-92. PubMed ID: 24841159
[TBL] [Abstract][Full Text] [Related]
12. [Lymph node metastases in ypT1/2 rectal cancer after neoadjuvant chemoradiotherapy : The Achilles heel of organ-preserving operative procedures?].
Sprenger T; Rothe H; Beissbarth T; Conradi LC; Kauffels A; Homayounfar K; Behnes CL; Rödel C; Liersch T; Ghadimi M
Chirurg; 2016 Jul; 87(7):593-601. PubMed ID: 27106241
[TBL] [Abstract][Full Text] [Related]
13. What is the role of lateral lymph node dissection in rectal cancer patients with clinically suspected lateral lymph node metastasis after preoperative chemoradiotherapy? A meta-analysis and systematic review.
Yang X; Yang S; Hu T; Gu C; Wei M; Deng X; Wang Z; Zhou Z
Cancer Med; 2020 Jul; 9(13):4477-4489. PubMed ID: 32352659
[TBL] [Abstract][Full Text] [Related]
14. [Surgical therapy of rectal carcinoma].
Bruch HP; Schwandner O; Keller R; Farke S; Schiedeck TH
Chirurg; 2003 Oct; 74(10):905-14. PubMed ID: 14605732
[TBL] [Abstract][Full Text] [Related]
15. Laparoscopic total mesorectal excision (TME) for rectal cancer surgery: long-term outcomes.
Leroy J; Jamali F; Forbes L; Smith M; Rubino F; Mutter D; Marescaux J
Surg Endosc; 2004 Feb; 18(2):281-9. PubMed ID: 14691716
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of residual lateral lymph node metastasis after neoadjuvant (chemo)radiotherapy in patients with advanced low rectal cancer.
Akiyoshi T; Toda S; Tominaga T; Oba K; Tomizawa K; Hanaoka Y; Nagasaki T; Konishi T; Matoba S; Fukunaga Y; Ueno M; Kuroyanagi H
BJS Open; 2019 Dec; 3(6):822-829. PubMed ID: 31832589
[TBL] [Abstract][Full Text] [Related]
17. Total mesorectal excision in the operative treatment of carcinoma of the rectum.
Enker WE; Thaler HT; Cranor ML; Polyak T
J Am Coll Surg; 1995 Oct; 181(4):335-46. PubMed ID: 7551328
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemoradiotherapy for rectal carcinoma: effects on anastomotic leak rate and postoperative bladder dysfunction after non-emergency sphincter-preserving anterior rectal resection. Results of the Quality Assurance in Rectal Cancer Surgery multicenter observational trial.
Garlipp B; Ptok H; Schmidt U; Meyer F; Gastinger I; Lippert H
Langenbecks Arch Surg; 2010 Nov; 395(8):1031-8. PubMed ID: 20711786
[TBL] [Abstract][Full Text] [Related]
19. [Parametric monitoring of the quality of total mesorectal excision and surgical treatment of rectal carcinoma results of a multicenter study].
Hoch J; Ferko A; Bláha M; Ryška A; Čapov I; Dušek L; Feit J; Grega M; Hermanová M; Hovorková E; Chmelová R; Kala Z; Klos D; Kodet R; Langer D; Hadži-Nikolov D; Örhalmi J; Páral J; Tichý M; Tučková I; Vjaclovský M; Vlček P
Rozhl Chir; 2016; 95(7):262-71. PubMed ID: 27523174
[TBL] [Abstract][Full Text] [Related]
20. [The role of magnetic resonance imaging to select patients for preoperative treatment in rectal cancer].
Rödel C; Sauer R; Fietkau R
Strahlenther Onkol; 2009 Aug; 185(8):488-92. PubMed ID: 19652930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
